Redwood City, CA – According to filings with the U.S. Securities and Exchange Commission, Juvena Therapeutics is raising $41,000,000.00 in new funding. Sources indicate as part of senior management Chief Executive Officer, Hanadie Yousef played a key role in securing the recent investment and it will aid in aggressively expanding the company, as well as broaden and accelerate product development.

About Juvena Therapeutics
Our mission is to unlock the therapeutic potential of secreted proteins and to engineer them into life-saving therapeutics. Juvena Therapeutics is a venture-backed biotechnology company unlocking the therapeutic potential of stem cell-secreted proteins and accelerating their development into life-saving therapeutics for chronic and age-related diseases.

To learn more about Juvena Therapeutics, visit http://www.juvenatherapeutics.com/

Contact:
Hanadie Yousef, Chief Executive Officer
650-223-5879
https://www.linkedin.com/in/hanadie-yousef-a2120026/

SOURCE: http://www.intelligence360.io
Copyright (c) 2022 SI360 Inc. All rights reserved